{"title":"Predictive value of pre-delivery serum b-human chorionic gonadotropin, fibrinogen, and homocysteine for pregnancy-induced hypertension.","authors":"Hani Lin, Hong Chen, Miaomiao Zhuo","doi":"10.5937/jomb0-52483","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>We aimed to investigate the relationship between pre-delivery serum b-human chorionic gonado - tropin (b-HCG), fibrinogen (FIB), and homocysteine (HCY) with hypertensive disorder complicating pregnancy (HDCP).</p><p><strong>Methods: </strong>This was a case-control study. 200 HDCP patients and 150 normal pregnant women were selected as study subjects. Fasting cubital venous blood samples were collected to measure serum triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL), and lowdensity lipoprotein (LDL), as well as b-HCG, FIB, and HCY levels. Pearson correlation analysis examined the relationship between b-HCG, FIB, HCY, and HDCP. Receiver operating characteristic (ROC) curve analysis evaluated the predictive value of these indicators for HDCP. Multiple logistic regression analysis identified risk factors (RFs) for HDCP.</p><p><strong>Results: </strong>Serum TG, TC, HDL, LDL, FIB, b-HCG, and HCY were greatly elevated in the HDCP group versus the control group (CG) (P<0.05). Serum b-HCG, FIB, and HCY showed notable positive correlations with HDCP (r=0.935, 0.547, 0.811; P<0.05), and the areas under the ROC curve (AUC) for predicting HDCP based on serum b-HCG, FIB, HCY, and their combination were 0.743, 0.659, 0.801, and 0.886, respectively (P<0.05). Lipid indicators and serum levels of FIB, b-HCG, and HCY were RFs for HDCP.</p><p><strong>Conclusions: </strong>Pregnant women with HDCP exhibited markedly elevated serum lipid levels and FIB, b-HCG, and HCY levels before delivery, which can serve as predictive indicators for HDCP.</p>","PeriodicalId":16175,"journal":{"name":"Journal of Medical Biochemistry","volume":"44 2","pages":"235-243"},"PeriodicalIF":2.0000,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12085184/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Biochemistry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.5937/jomb0-52483","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: We aimed to investigate the relationship between pre-delivery serum b-human chorionic gonado - tropin (b-HCG), fibrinogen (FIB), and homocysteine (HCY) with hypertensive disorder complicating pregnancy (HDCP).
Methods: This was a case-control study. 200 HDCP patients and 150 normal pregnant women were selected as study subjects. Fasting cubital venous blood samples were collected to measure serum triglycerides (TG), total cholesterol (TC), high-density lipoprotein (HDL), and lowdensity lipoprotein (LDL), as well as b-HCG, FIB, and HCY levels. Pearson correlation analysis examined the relationship between b-HCG, FIB, HCY, and HDCP. Receiver operating characteristic (ROC) curve analysis evaluated the predictive value of these indicators for HDCP. Multiple logistic regression analysis identified risk factors (RFs) for HDCP.
Results: Serum TG, TC, HDL, LDL, FIB, b-HCG, and HCY were greatly elevated in the HDCP group versus the control group (CG) (P<0.05). Serum b-HCG, FIB, and HCY showed notable positive correlations with HDCP (r=0.935, 0.547, 0.811; P<0.05), and the areas under the ROC curve (AUC) for predicting HDCP based on serum b-HCG, FIB, HCY, and their combination were 0.743, 0.659, 0.801, and 0.886, respectively (P<0.05). Lipid indicators and serum levels of FIB, b-HCG, and HCY were RFs for HDCP.
Conclusions: Pregnant women with HDCP exhibited markedly elevated serum lipid levels and FIB, b-HCG, and HCY levels before delivery, which can serve as predictive indicators for HDCP.
期刊介绍:
The JOURNAL OF MEDICAL BIOCHEMISTRY (J MED BIOCHEM) is the official journal of the Society of Medical Biochemists of Serbia with international peer-review. Papers are independently reviewed by at least two reviewers selected by the Editors as Blind Peer Reviews. The Journal of Medical Biochemistry is published quarterly.
The Journal publishes original scientific and specialized articles on all aspects of
clinical and medical biochemistry,
molecular medicine,
clinical hematology and coagulation,
clinical immunology and autoimmunity,
clinical microbiology,
virology,
clinical genomics and molecular biology,
genetic epidemiology,
drug measurement,
evaluation of diagnostic markers,
new reagents and laboratory equipment,
reference materials and methods,
reference values,
laboratory organization,
automation,
quality control,
clinical metrology,
all related scientific disciplines where chemistry, biochemistry, molecular biology and immunochemistry deal with the study of normal and pathologic processes in human beings.